Conversion therapy using transarterial chemoembolization plus tislelizumab for unresectable hepatocellular carcinoma: effects on tumor necrosis and anti-tumor immune response

Clinical & Translational Oncology 2026

View at publisher

Authors: Qihang Yao, Guangwen Chen, Y. Y. Yu, Zeping Chen, An Xiao, Xueqian Xie, Qingguo Wang, Desheng Chen, Hongcheng Sun

DOI: 10.1007/s12094-025-04159-7

Cited by: 0

References: 35

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Hepatitis B Virus Studies Cancer Immunotherapy and Biomarkers

References 35